{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:02:50Z","timestamp":1790370170633,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.surg.2026.110587","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:18:47Z","timestamp":1788275927000},"page":"110587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone-modifying agents may alter biochemical presentation and operative findings in primary hyperparathyroidism"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8442-350X","authenticated-orcid":false,"given":"Abigail C.","family":"Chmiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genesys","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga M.","family":"Yalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Gillanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John A.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110587_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2026.110587_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.metabol.2017.10.003","article-title":"Bone disease in primary hyperparathyroidism","volume":"80","author":"Makras","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.surg.2026.110587_bib3","series-title":"Primary Hyperparathyroidism. In: StatPearls [Internet]","author":"Helbing","year":"2026"},{"key":"10.1016\/j.surg.2026.110587_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2026.110587_bib5","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2026.110587_bib6","series-title":"Hyperparathyroidism (Primary): B Diagnosis, Assessment and Initial Management","year":"2019"},{"key":"10.1016\/j.surg.2026.110587_bib7","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.surg.2026.110587_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.surg.2026.110587_bib9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.surg.2026.110587_bib10","first-page":"184","article-title":"Primary hyperparathyroidism: pathophysiology and impact on bone","volume":"163","author":"Khan","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.surg.2026.110587_bib11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.surg.2026.110587_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.coph.2006.03.005","article-title":"Recent advances in understanding the mechanism of action of bisphosphonates","volume":"6","author":"Coxon","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.surg.2026.110587_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1098841","article-title":"Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"14","author":"Rajput","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.surg.2026.110587_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S8756-3282(00)00260-X","article-title":"Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment","volume":"26","author":"Steiniche","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.surg.2026.110587_bib15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.surg.2012.08.015","article-title":"Changes in bone mineral density after surgical intervention for primary hyperparathyroidism","volume":"152","author":"Dy","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110587_bib16","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: a review","volume":"328","author":"Walker","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2026.110587_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.surg.2026.110587_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.surg.2026.110587_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.surg.2007.07.023","article-title":"Consequences of parathyroidectomy in patients with \u201cmild\u201d sporadic primary hyperparathyroidism","volume":"142","author":"Carneiro-Pla","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110587_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.surg.2016.08.054","article-title":"Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism","volume":"161","author":"Lim","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110587_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.amjsurg.2022.03.007","article-title":"The impact of patient age on practice patterns and outcomes for primary hyperparathyroidism","volume":"224","author":"Sutton","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2026.110587_bib22","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1245\/s10434-013-3402-y","article-title":"Parathyroid surgery in the elderly: should minimally invasive surgery be abandoned?","volume":"21","author":"Mekel","year":"2014","journal-title":"Ann Surg Oncol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602600512X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602600512X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:32:52Z","timestamp":1790368372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003960602600512X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S003960602600512X"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110587","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone-modifying agents may alter biochemical presentation and operative findings in primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110587"}}